{
    "Trade/Device Name(s)": [
        "HemosIL PT-Fibrinogen HS PLUS"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K060931",
    "Predicate Device Reference 510(k) Number(s)": [
        "K933252"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GJS",
        "GIS"
    ],
    "Summary Letter Date": "May 2, 2005",
    "Summary Letter Received Date": "April 5, 2006",
    "Submission Date": "April 4, 2006",
    "Regulation Number(s)": [
        "21 CFR 864.7750",
        "21 CFR 864.7340"
    ],
    "Regulation Name(s)": [
        "Prothrombin time test",
        "Fibrinogen determination system"
    ],
    "Analyte Class(es)": [
        "coagulation"
    ],
    "Analyte(s)": [
        "Prothrombin Time",
        "Fibrinogen"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "IL Coagulation Systems",
        "ACL Futura",
        "ACL Advance"
    ],
    "Method(s)/Technology(ies)": [
        "Clotting assay",
        "Calcium thromboplastin-based detection"
    ],
    "Methodologies": [
        "Coagulation time measurement"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL PT-Fibrinogen HS PLUS high-sensitivity reagent for PT and fibrinogen measurement on IL coagulation analyzers",
    "Indications for Use Summary": "High sensitivity calcium thromboplastin reagent for simultaneous Prothrombin Time and Fibrinogen determination to evaluate extrinsic coagulation pathway and monitor oral anticoagulant therapy in citrated plasma on IL Coagulation Systems",
    "fda_folder": "Hematology"
}